Navigation Links
GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging

Lamictal, an antiepileptic drug, is one of the several prescription drugs that has encountered the problem of dispensing errors.

Dispensing errors are often a result of miscommunication, which can include poor hand writing of the prescription and confusion between drugs with similar names.//

It is important for patients with epilepsy not to have an interruption in treatment because it could lead to consequence such as status epilepticus.

Conversely, those patients that do not have epilepsy could be placed at unnecessary risk of adverse events, including serious rash, if they are mistakenly given Lamictal.

The most common dispensing errors have been between Lamisil(R), an antifungal tablet and Lamictal.In these instances, either Lamisil was substituted for Lamictal or Lamictal was substituted for Lamisil.

GlaxoSmithKline announced that it has substantially changed the appearance of container labeling and packaging in an effort to reduce the potential for dispensing errors involving its antiepileptic drug Lamictal(lamotrigene).

As a result, GlaxoSmithKline has worked closely with the Food and Drug Administration(FDA) in an effort to educate pharmacists and physicians about the potential for Lamictal dispensing errors.

The container label change is a part of this effort.These efforts reinforce the importance of clear communication between physicians, phamacists and patients.


'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline To Cultivate Non-Smoking Environment
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. FDA Mislead On Asthma Drug By GlaxoSmithKline
4. GlaxoSmithKline Defends Its Products
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/25/2016)... ... 2016 , ... "FCPX LUT Intense allows users to cycle through different high-contrast ... CEO of Pixel Film Studios. , With the FCPX LUT Intense Plugin ... to their footage. A LUT is a Lookup Table that contains a mathematical formula ...
(Date:5/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... as the Medical Director of its new DeSoto facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:5/24/2016)... ... May 24, 2016 , ... According to an article ... of people randomly assigned to reduce the amount of calories they consumed by 25% ... in body weight enjoyed better sleep, improved quality of life, and enhanced sexual function ...
(Date:5/24/2016)... IL (PRWEB) , ... May 24, 2016 , ... To ... created a new research award to examine gender differences in lung cancer. Today, the ... Research Innovation Project: Lung Cancer in Women Award, funded by the American Lung Association’s ...
(Date:5/24/2016)... ... May 24, 2016 , ... Jericho Project has named LaToya ... she will be responsible for fundraising and communications for the nationally-acclaimed nonprofit, working closely ... Jericho Project working to end homelessness at its roots. , “LaToya Williams-Belfort is ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... Open Access Journal Focusing ... Elsevier , a world-leading provider of scientific, ... the launch of Clinical Neurophysiology ... on clinical practice issues in clinical neurophysiology. The journal ... values and didactic reviews. It is an official journal ...
(Date:5/23/2016)... May 23, 2016 Global Paclitaxel ... pages, profiles 12 companies and the Paclitaxel analysis in ... on the industry and its players. This ... in nature, details the current state of the industry ... definitions, classifications, applications and industry chain structure. The Paclitaxel ...
(Date:5/23/2016)... Clarifying Vision - Prospects and Developments in ... What can be expected from the Ophthalmic ... the fastest rates? This visiongain report shows ... and prospects. ,Our 190-page report provides ... areas in the industry and the future market prospects. ...
Breaking Medicine Technology: